Order results by:
| Issue | Title | |
| Vol 14, No 4 (2021) | Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate | Abstract similar documents |
| I. Yu. Torshin, A. M. Lila, O. A. Gromova | ||
| "... Background. Long-term use of chondroprotective agents – chondroitin sulfate (CS) and glucosamine ..." | ||
| Vol 15, No 1 (2022) | Perioperative pharmacotherapy for endoprosthetics: potential of chondroitin sulfate and glucosamine sulfate | Abstract similar documents |
| I. Yu. Torshin, T. B. Minasov, N. V. Zagorodniy, A. M. Lila, O. A. Gromova | ||
| "... and glucosamine sulfate includes inhibition of NF-κB cascade, toll-like receptors, pro-inflammatory cytokines ..." | ||
| Vol 15, No 3 (2022) | Prospects for the use of chondroitin sulfate and glucosamine sulfate in the treatment of patients with obesity-associated osteoarthritis (metabolic syndrome) | Abstract similar documents |
| I. Yu. Torshin, О. A. Gromova, A. M. Lila | ||
| "... metabolism is also mediated by impaired genomic DNA methylation. Exogenous CS and glucosamine sulfate (GS ..." | ||
| Vol 13, No 2 (2020) | Is it worthwhile rethinking the positive experience of the last 50 years of using chondroitin sulfates against atherosclerosis? | Abstract similar documents |
| A. M. Lila, I. Yu. Torshin, O. A. Gromova | ||
| "... Chondroitin sulfate (CS) and glucosamine sulfate (GS) are used in the treatment of osteoarthritis ..." | ||
| Vol 13, No 3 (2020) | Chemomicrobiomic analysis of glucosamine sulfate, prebiotics and non-steroidal anti-inflammatory drugs | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. V. Naumov, V. A. Maksimov | ||
| "... of glucosamine sulfate (GS), diclofenac, acetylsalicylic acid (ASA), and three prebiotics (lactose, lactulose ..." | ||
| Vol 16, No 4 (2023) | Oncoprotective effects of chondroprotectors: glucosamine, chondroitin sulfate and undenatured type II collagen | Abstract similar documents |
| I. Yu. Torshin, A. G. Chuchalin, O. A. Gromova | ||
| "... effects of chondroprotectors: chondroitin sulfate (CS), glucosamine (including glucosamine sulfate, GS ..." | ||
| Online First | Osteoarthritis therapy misconcepts | Abstract similar documents |
| O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
| "... ), glucosamine sulfate (GS), diacerein, avocado soybean unsaponifiables, hyaluronic acid (HA) for intra-articular ..." | ||
| Vol 13, No 4 (2020) | Acute issues in the pharmacotherapy of hand osteoarthritis | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. V. Naumov, L. V. Vasilyeva, Ye. F. Yevstratova, А. N. Gromov | ||
| "... therapy include steroid drugs, chondroitin sulfate (CS), glucosamine sulfate (GS), and vitamin D ..." | ||
| Vol 14, No 4 (2021) | Prospects of using chondroprotectors for the treatment of pulmonary pathology | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin | ||
| "... Background. The complex mechanisms of action of chondroitin sulfate (CS) and glucosamine sulfate ..." | ||
| Vol 16, No 2 (2023) | From misconceptions to reasonable osteoarthritis patients therapy | Abstract similar documents |
| O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov | ||
| "... of European experts (2019): chondroitin sulfate (CS), glucosamine sulfate (GS), diacerein, avocado soybean ..." | ||
| Vol 16, No 3 (2023) | Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy | Abstract similar documents |
| O. A. Shavlovskaya, О. А. Gromova, A. Yu. Kochish, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova | ||
| "... sulfate, glucosamine sulfate, undenatured type II collagen, vitamin D. Each of them has symptom-modifying ..." | ||
| Vol 16, No 4 (2023) | DMOADs and DMARDs in the treatment of patients with joint and spine diseases | Abstract PDF (Eng) similar documents |
| O. A. Shavlovskaya | ||
| Vol 14, No 2 (2021) | Chemoreactome screening of pharmaceutical effects on SARS-CoV-2 and human virome to help decide on drug-based COVID-19 therapy | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin, Yu. I. Zhuravlev | ||
| "... stress. Glucosamine sulfate was found to have the best safety profile and minimum effects on the healthy ..." | ||
| Vol 14, No 1 (2021) | Differences in the standardization of medicinal products based on extracts of chondroitin sulfate | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, B. Ts. Zaychik, E. V. Shikh, A. O. Ruzhitskiy, A. N. Galustyan, I. S. Sardaryan, I. V. Sarvilina | ||
| "... chondroitin sulfate (CS) based on natural extracts. Material and methods. Five samples were studied for each ..." | ||
| Vol 12, No 4 (2019) | Comparative clinical and economic analysis of using SYSADOA drugs containing chondroitin sulphate or influencing its biosynthesis in the treatment of patients with stage II knee osteoarthritis | Abstract similar documents |
| I. V. Sarvilina, A. N. Galustyan, A. K. Hadzhidis, I. S. Sardaryan, N. V. Lavrov, O. A. Gromova, Yu. S. Prokofieva | ||
| "... containing chondroitin sulfate or modifying its biosynthesis in patients with stage II knee osteoarthritis ..." | ||
| Vol 13, No 4 (2020) | Meta-analysis of clinical trials of osteoarthritis treatment effectiveness with Chondroguard | Abstract similar documents |
| I. Yu. Torshin, A. M. Lila, A. V. Naumov, A. Yu. Kochish, L. I. Alekseeva, E. A. Taskina, I. V. Sarvilina, A. N. Galustyan, A. N. Gromov, A. K. Khadzhidis, L. V. Vasilieva, E. F. Yevstratova, M. I. Udovika, O. A. Gromova | ||
| Vol 14, No 3 (2021) | The concept of syndromic diagnoses of osteoarthritis and back pain as a cause of therapy failure | Abstract similar documents |
| M. V. Putilina, N. V. Teplova, O. S. Gerasimova | ||
| "... -acting drugs containing chondroitin sulfate (Chondroguard®), which will accelerate the onset ..." | ||
| Vol 17, No 4 (2024) | Study of the effect of human placenta hydrolysate in a new model of metabolic-associated fatty liver disease with iron overload | Abstract similar documents |
| T. E. Bogacheva, O. A. Gromova, I. Yu. Torshin, V. I. Demidov, A. G. Kalacheva, A. A. Garanin, I. V. Gogoleva, L. E. Fedotova, O. A. Limanova, А. N. Mnatsakanyan, N. Yu. Zhidomorov, T. R. Grishina | ||
| "... , a model of liver iron overload was reproduced by intraperitoneal administration of iron sulfate for 12 ..." | ||
| Vol 16, No 3 (2023) | The role of ferritin in liver disease assessment | Abstract similar documents |
| V. G. Radchenko, V. B. Grinevich, E. S. Ivanyuk, L. B. Lazebnik | ||
| "... Background. Ferritin is an important integral and diagnostic marker of liver diseases. In 1/3 ..." | ||
| Vol 8, No 3 (2015) | NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL | Abstract similar documents |
| D. V. Blinov | ||
| "... Introduction. Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as an important ..." | ||
| Vol 16, No 1 (2023) | Development of a verified osteoarthritis risk scale based on a cross-sectional study of clinical and anamnestic parameters and pharmacological anamnesis of patients | Abstract similar documents |
| I. Yu. Torshin, А. М. Lila, N. V. Zagorodniy, А. G. Nazarenko, О. N. Tkacheva, Е. N. Dudinskaya, L. I. Alekseeva, Е. А. Taskina, I. V. Sarvilina, О. А. Shavlovskaya, A. B. Danilov, Т. B. Minasov, А. N. Galustyan, S. I. Malyavskaya, А. N. Gromov, Е. Yu. Egorova, L. V. Vasilyeva, E. F. Evstratova, I. V. Gogoleva, L. E. Fedotova, М. I. Udovika, V. A. Maximov, А. S. Povzun, О. А. Gromova | ||
| "... of chondroitin sulfate (CS) and glucosamine sulfate (GS) is promising. The evidence for CS/GS is extensive ..." | ||
| Vol 16, No 3 (2023) | An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis | Abstract similar documents |
| M. Imawari, M. Nagase, I. Yu. Torshin, O. A. Gromova | ||
| "... ® in the treatment of nonalcoholic fatty liver disease (NAFLD) in a clinical trial. Material and methods. The study ..." | ||
| Vol 17, No 1 (2024) | A clinical case of ectopic pregnancy with localization in the liver | Abstract similar documents |
| A. Е. Voynovskiy, О. A. Zaitseva, A. G. Solopova, D. V. Blinov, М. P. Malykh-Bakhtina, G. К. Bykobshchenko | ||
| "... The article describes a clinical case of ectopic pregnancy with localization in the liver ..." | ||
| Vol 15, No 1 (2022) | Application of chondroprotective agents to inhibit osteodestructive processes in the subchondral bone in patients with osteoarthritis | Abstract PDF (Eng) similar documents |
| О. А. Gromova, А. М. Lila, I. Yu. Torshin, I. А. Reier | ||
| "... agents (chondroitin sulfate (CS), glucosamine sulfate (GS), and undenaturated collagen) block ..." | ||
| Vol 8, No 1 (2015) | PHARMACOEPIDEMIOLOGICAL EVALUATION OF HEPATOTROPIC THERAPY IN REAL CLINICAL PRACTICE | Abstract similar documents |
| D. V. Blinov, U. V. Zimovina, T. I. Ushakova | ||
| "... Chronic liver diseases are a serious problem and a common cause of suffering and death in all ..." | ||
| Vol 14, No 1 (2021) | Perspectives of osteoarthritis prevention and therapy personification based on the analysis of comorbid background, genetic polymorphisms and microelement status | Abstract similar documents |
| I. Yu. Torshin, A. M. Lila, A. V. Naumov, I. S. Sardaryan, T. E. Bogacheva, T. R. Grishina, I. V. Gogoleva, O. A. Limanova, O. A. Gromova | ||
| "... on the obtained results the prospects for the use of chondroitin sulfate and glucosamine sulfate in patients ..." | ||
| Vol 9, No 4 (2016) | PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY) | Abstract similar documents |
| D. Kh. Kalimullina, A. S. Yurkina, T. I. Ushakova, D. V. Blinov | ||
| "... Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as an important problem ..." | ||
| Vol 10, No 1 (2017) | THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OUTPATIENTS IN THE FAR EAST FEDERAL DISTRICT | Abstract similar documents |
| V. A. Nevzorova, M. V. Mokshina, T. A. Brodskaya, D. A. Vasil’chenkov, D. V. Blinov, T. I. Ushakova | ||
| "... , stimulates medical experts to closely study the epidemiology of non-alcoholic fatty liver disease (NAFLD ..." | ||
| Vol 9, No 2 (2016) | EPIDEMIOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE IN NOVOSIBIRSK (SIBERIAN FEDERAL DISTRICT): REGIONAL DATA OF OPEN MULTICENTER PROSPECTIVE STUDY DIREG 2 | Abstract similar documents |
| V. V. Tsukanov, A. S. Yurkina, T. A. Ushakova, D. V. Blinov | ||
| "... Non-alcoholic fatty liver disease (NAFLD) is an important medical and social problem. Essentially ..." | ||
| Vol 16, No 4 (2023) | Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C | Abstract similar documents |
| I. A. Narkevich, E. A. Tsitlionok | ||
| "... genotype 1 and a mild degree of liver fibrosis. A total of 18 international nonproprietary names (17 trade ..." | ||
| Vol 17, No 3 (2024) | The influence of the combination of methanolic extract Scurrula atropurpurea (Blume) and Dendrophthoe pentandra on rat liver function and structure | Abstract PDF (Eng) similar documents |
| N. Athiroh, N. J. Mubarakati, Yu. Purnomo | ||
| "... (MESA-DP) on rat liver function and structure using serological and histopathological analysis ..." | ||
| Vol 14, No 3 (2021) | Pharmacoeconomic analysis of the application of strong opioids for the treatment of chronic pain syndrome in patients with pancreatic cancer | Abstract similar documents |
| O. P. Bobrova, S. K. Zyryanov, N. A. Shnayder, M. M. Petrova | ||
| "... tree in patients receiving morphine sulfate (n=45) and fentanyl TTS (n=45) for pain relief ..." | ||
| Vol 16, No 2 (2023) | Pharmacoepidemiological and drug interaction analysis in the treatment of chronic renal and hepatic failure | Abstract similar documents |
| O. V. Zhukova, D. S. Fokina, O. V. Ruina, M. V. Khazov | ||
| "... for liver/kidney transplantation. Material and methods. The study was conducted on the basis ..." | ||
| Vol 18, No 1 (2025) | Amelioration of histopathological damage in mice with induced hyperlipidemia by terpenes and phytosterols extracted from Iraqi chickpea | Abstract PDF (Eng) similar documents |
| N. R. Hwerif, A. R. Abu Raghif, E. J. Kadhim | ||
| "... ), and total serum bilirubin (TSB) levels. The animals were sacrificed, then their liver and heart organs were ..." | ||
| Vol 13, No 4 (2020) | Peptides contained in the composition of Laennec that contribute to the treatment of hyperferritinemia and iron overload disorders | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, V. A. Maksimov, A. G. Chuchalin, V. G. Zgoda, А. N. Gromov, O. V. Tikhonova | ||
| "... Introduction. Hemosiderosis is a pathologic condition that accompanies liver, lung, and other ..." | ||
| Vol 16, No 3 (2023) | Possibilities of using coenzyme Q10 for the treatment of diseases associated with mitochondrial dysfunction and chronic inflammation | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. N. Gromov | ||
| "... to the development of atherosclerosis, liver and pancreas pathologies, and neurodegeneration. Material and methods ..." | ||
| Vol 16, No 4 (2023) | Nephroprotective peptides of Laennec® in the context of pharmacotherapy for nephro-hepato-metabolic disorders | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, A. N. Gromov, O. V. Tikhonova | ||
| "... Background. Renal-hepatic dysfunction, which often occurs in liver dysfunction, requires the use ..." | ||
| Online First | Analysis of clinical and epidemiological interactions of phenol and phthalate levels in blood and urine with anamnestic and biochemical health measures during the formation of multisystem organ pathology | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, T. E. Bogacheva, A. N. Gromov | ||
| "... destruction markers, hematopoiesis disorders (decreased hemoglobin and mean corpuscular volume), liver ..." | ||
| Vol 13, No 2 (2020) | A modern conception of postcholecystectomy syndrome (based on the materials of the Advisory Board held on May 4, 2019 in Almaty, Kazakhstan) | Abstract similar documents |
| A. V. Nersesov, D. A. Kaibullaeva, O. S. Vasnev, L. K. Tashenova, M. M. Sakhipov, G. T. Berestimov, G. A. Akhmetzhanova, O. T. Ibekenov, M. O. Doskhanov, N. M. Zhumazhanov, Zh. M. Balzhanov, B. A. Aitmoldin, E. A. Toleubaev, E. M. Laryushina, K. N. Zhumagulov, G. N. Sobirova, S. I. Umarova, Yu. O. Shulpekova, A. V. Okhlobystin | ||
| "... (“postcholecystectomy syndrome”). Postcholecystectomy syndrome includes heterogeneous disorders of liver, pancreas ..." | ||
| Vol 14, No 4 (2021) | Economic burden of chronic viral hepatitis C | Abstract similar documents |
| R. A. Yakhina, I. A. Lakman, D. A. Valishin, R. Kh. Bakhitova | ||
| "... , the distribution of patients by the degree of liver fibrosis is taken into account. In 50% of the studies reviewed ..." | ||
| Vol 16, No 1 (2023) | Modern biomarkers of acute kidney injury | Abstract similar documents |
| D. I. Korabelnikov, M. O. Magomedaliev | ||
| 1 - 43 of 43 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
